| Product Code: ETC8572647 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of unfractionated heparin into New Zealand in 2024 continued to be dominated by top exporting countries such as the USA, Mexico, Austria, Dominican Republic, and Brazil. The market remained highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 was strong at 6.59%, with a notable growth rate of 4.63% from 2023 to 2024. This data suggests a steady demand for unfractionated heparin in New Zealand, with key suppliers maintaining their strong presence in the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Unfractionated Heparin Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Unfractionated Heparin Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Unfractionated Heparin Market - Industry Life Cycle |
3.4 New Zealand Unfractionated Heparin Market - Porter's Five Forces |
3.5 New Zealand Unfractionated Heparin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 New Zealand Unfractionated Heparin Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 New Zealand Unfractionated Heparin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in New Zealand |
4.2.2 Growing geriatric population requiring anticoagulant therapy |
4.2.3 Rising awareness about the benefits of unfractionated heparin in various medical procedures |
4.3 Market Restraints |
4.3.1 High cost associated with unfractionated heparin therapy |
4.3.2 Stringent regulatory requirements for the approval and usage of unfractionated heparin |
4.3.3 Competition from alternative anticoagulant therapies in the market |
5 New Zealand Unfractionated Heparin Market Trends |
6 New Zealand Unfractionated Heparin Market, By Types |
6.1 New Zealand Unfractionated Heparin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Unfractionated Heparin Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 New Zealand Unfractionated Heparin Market Revenues & Volume, By Bovine, 2021- 2031F |
6.1.4 New Zealand Unfractionated Heparin Market Revenues & Volume, By Porcine, 2021- 2031F |
6.2 New Zealand Unfractionated Heparin Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Unfractionated Heparin Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 New Zealand Unfractionated Heparin Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 New Zealand Unfractionated Heparin Market Revenues & Volume, By Others, 2021- 2031F |
7 New Zealand Unfractionated Heparin Market Import-Export Trade Statistics |
7.1 New Zealand Unfractionated Heparin Market Export to Major Countries |
7.2 New Zealand Unfractionated Heparin Market Imports from Major Countries |
8 New Zealand Unfractionated Heparin Market Key Performance Indicators |
8.1 Number of unfractionated heparin prescriptions filled annually |
8.2 Rate of adoption of unfractionated heparin in different medical procedures |
8.3 Patient satisfaction levels with unfractionated heparin therapy |
9 New Zealand Unfractionated Heparin Market - Opportunity Assessment |
9.1 New Zealand Unfractionated Heparin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 New Zealand Unfractionated Heparin Market Opportunity Assessment, By Application, 2021 & 2031F |
10 New Zealand Unfractionated Heparin Market - Competitive Landscape |
10.1 New Zealand Unfractionated Heparin Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Unfractionated Heparin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |